← Open Payments lookup

KEISHA YAHAGI: Open Payments

NPI 1073953394 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,671 in 120 payments from 12 companies in 2025. Trend: 2023 $1,148 · 2024 $1,756 · 2025 $1,671

Food & beverage: $1,671
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc13$305
E.R. Squibb & Sons, L.L.C.36$273
Alkermes, Inc.14$224
Neurocrine BioSciences, Inc.6$177
ABBVIE INC.14$171
Teva Pharmaceuticals USA, Inc.11$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$141
Otsuka America Pharmaceutical, Inc.12$138
Lundbeck LLC2$35
Vanda Pharmaceuticals Inc.1$20

Products named: INVEGA SUSTENNA, COBENFY, ARISTADA, INGREZZA, VRAYLAR, UZEDY, CAPLYTA, REXULTI.

Industry payments across TX — which companies pay providers there.